Prevalence and outcomes of gastrointestinal manifestations in an Australian Scleroderma cohort

Objectives The gastrointestinal tract (GIT) is the most commonly affected internal organ in systemic sclerosis (SSc). We sought to determine the prevalence and impact of GIT symptoms on survival and patient‐reported outcomes. Methods 907 consecutive patients from the Australian Scleroderma Cohort Study (ASCS) who had prospectively completed the University of California Los Angeles Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 questionnaire (UCLA GIT) between 2015 and 2021 were included. The association between UCLA GIT scores and physical function (SHAQ), QoL (SF‐36), mood (PROMIS anxiety and depression domains), fatigue (FACIT‐fatigue score) and employment was investigated using multivariable population‐averaged panel models using Generalized Estimating Equations (GEE). Kaplan‐Meier curves and multivariable Cox proportional hazard regression model were used to evaluate survival according to total UCLA GIT scores. Results GIT symptoms were reported in 87% of participants with 46‐52% reporting moderate to very severe symptoms of reflux, distension, diarrhoea and constipation. Higher total UCLA GIT scores were associated with worse QoL, physical function, fatigue, anxiety and depression (p<0.001). In multivariable GEE analysis, moderate and severe to very severe total scores, reflux and distension scores were associated with worse physical function, QoL, fatigue, anxiety and depression compared to those with mild scores (p<0.05). Patients with severe total scores and diarrhoea scores were more likely to be unemployed compared to those with mild scores (p<0.05). UCLA GIT total scores were not independently associated with mortality in our cohort. Conclusion GIT manifestations are common in SSc and negatively impact QoL, physical function and employment but are not directly associated with increased mortality.